GeneDx Corp.
(WGS)
undefined
undefined%
At close: undefined
75.43
-0.01%
After-hours Dec 13, 2024, 04:00 PM EST
Company Description
GeneDx Holdings Corp. is a patient centered health intelligence company.
It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories.
The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs.
The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
GeneDx Corp.
Country | United States |
IPO Date | Nov 4, 2020 |
Industry | Medical - Healthcare Information Services |
Sector | Healthcare |
Employees | 1,000 |
CEO | Katherine A. Stueland |
Contact Details
Address: North Tower Stamford, Connecticut United States | |
Website | http://www.genedx.com |
Stock Details
Ticker Symbol | WGS |
Exchange | NASDAQ |
Fiscal Year | n/a |
Reporting Currency | USD |
CIK Code | 0001818331 |
CUSIP Number | 81663L200 |
ISIN Number | US81663L2007 |
Employer ID | 85-1966622 |
SIC Code | 8000 |
Key Executives
Name | Position |
---|---|
Katherine A. Stueland | President, Chief Executive Officer & Director |
Heidi C. Chen J.D. | Chief Legal Officer |
Kevin Feeley CPA | Chief Financial Officer |
Britt Johnson | Head of Medical Affairs |
Eric Olivares Ph.D. | Chief Product & Technology Officer |
Jami Biliboaca | Head of People Strategy |
Karen Ponchner | Head of Operations |
Melanie Duquette | Chief Growth Officer |
Paul Kruszka FACMG, M.D., M.P.H. | Chief Medical Officer |
Sabrina Dunbar | Chief of Staff |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 11, 2024 | 4 | Filing |
Dec 11, 2024 | 4 | Filing |
Dec 03, 2024 | 4 | Filing |
Nov 25, 2024 | 4 | Filing |
Nov 21, 2024 | 4/A | [Amend] Filing |
Nov 21, 2024 | 4 | Filing |
Nov 20, 2024 | SC 13D/A | [Amend] Filing |
Nov 19, 2024 | 4 | Filing |
Nov 19, 2024 | SC 13D/A | [Amend] Filing |
Nov 19, 2024 | 4 | Filing |